scholarly article | Q13442814 |
P2093 | author name string | Jones B | |
Bayer L | |||
Serafin M | |||
Eggermann E | |||
Machard D | |||
Mühlethaler M | |||
Saint-Mleux B | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1571-1575 | |
P577 | publication date | 2001-11-01 | |
P1433 | published in | European Journal of Neuroscience | Q5412733 |
P1476 | title | Orexins (hypocretins) directly excite tuberomammillary neurons | |
P478 | volume | 14 |
Q57805525 | Activation of orexin system facilitates anesthesia emergence and pain control |
Q37395932 | Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. |
Q44905905 | Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior |
Q44494845 | Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats |
Q30395479 | Comprehensive Behavioral Analysis of Male Ox1r (-/-) Mice Showed Implication of Orexin Receptor-1 in Mood, Anxiety, and Social Behavior |
Q24634619 | Control of sleep and wakefulness |
Q38152336 | Current and emerging options for the drug treatment of narcolepsy |
Q35700616 | Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness |
Q38111376 | Differential roles of orexin receptors in the regulation of sleep/wakefulness. |
Q44472346 | Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes |
Q40654209 | Effects of Orexin (Hypocretin) on GIRK Channels |
Q33780634 | Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. |
Q80391931 | Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons |
Q53417068 | Functional Changes Induced by Orexin A and Adiponectin on the Sympathetic/Parasympathetic Balance. |
Q30489125 | Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation |
Q34990730 | Functions of the orexinergic/hypocretinergic system |
Q48504270 | GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. |
Q30361534 | Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep. |
Q36075142 | Histamine and motivation. |
Q36756384 | Histamine and schizophrenia |
Q39648815 | Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex |
Q38191600 | Hypocretin (orexin) regulation of sleep-to-wake transitions |
Q55442317 | Hypocretin as a Hub for Arousal and Motivation. |
Q37596060 | Hypocretin/orexin in arousal and stress |
Q44931357 | Hypocretinergic control of spinal cord motoneurons. |
Q46211808 | Hypothalamic Tuberomammillary Nucleus Neurons: Electrophysiological Diversity and Essential Role in Arousal Stability. |
Q30311232 | Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. |
Q37807702 | Hypothalamus, hypocretins/orexin, and vigilance control |
Q38654594 | Investigational therapies for the treatment of narcolepsy. |
Q48345029 | Long-term alteration in bodyweight and food restriction does not affect the gene expression of either preproorexin or prodynorphin in the sheep |
Q44283284 | Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background |
Q36346477 | Metabolic state signalling through central hypocretin/orexin neurons. |
Q37999096 | Models for narcolepsy with cataplexy drug discovery |
Q33351116 | Narcolepsy and orexins: an example of progress in sleep research |
Q34578843 | Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence |
Q37807663 | Neurobiology of waking and sleeping |
Q34571598 | Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. |
Q34518670 | Neuropharmacology of Sleep and Wakefulness |
Q36393701 | Neuropharmacology of Sleep and Wakefulness: 2012 Update |
Q27686789 | New approaches for the study of orexin function |
Q35011921 | Novel therapies for narcolepsy |
Q42465047 | Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons |
Q38077489 | Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status |
Q42879296 | Orexin directly excites orexin neurons through orexin 2 receptor |
Q30569775 | Orexin neurons suppress narcolepsy via 2 distinct efferent pathways |
Q30498843 | Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice |
Q36880278 | Orexin, stress, and anxiety/panic states |
Q47799533 | Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors |
Q24650737 | Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models |
Q37522864 | Orexin/hypocretin receptor signalling: a functional perspective |
Q42494777 | Orexinergic innervation of the extended amygdala and basal ganglia in the rat. |
Q26822470 | Physiology of the orexinergic/hypocretinergic system: a revisit in 2012 |
Q57160068 | Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation |
Q27028141 | Role of orexin receptors in obesity: from cellular to behavioral evidence |
Q33915391 | Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity |
Q28069502 | Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis |
Q47371999 | Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. |
Q44132550 | Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. |
Q37380606 | Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines |
Q30362407 | The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. |
Q38414049 | The Neurobiology of Anesthetic Emergence |
Q34502802 | The Neurobiology of Sleep and Wakefulness |
Q38115678 | The histaminergic network in the brain: basic organization and role in disease |
Q26830704 | The hypocretins/orexins: integrators of multiple physiological functions |
Q34623823 | The hypocretins: setting the arousal threshold |
Q48810476 | The influence of orexins on the firing rate and pattern of rat intergeniculate leaflet neurons--electrophysiological and immunohistological studies. |
Q36003547 | The wake-promoting effects of hypocretin-1 are attenuated in old rats. |
Q44357295 | The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. |
Q34668388 | To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance |
Q57815721 | Towards a better understanding of anesthesia emergence mechanisms: Research and clinical implications |
Q26795524 | Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states |
Q80674261 | [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders] |
Search more.